QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A10F0BAC488BB1596C5F0CE4F667FB3F;jsessionid=4604EAF85061B7D2112CE838C4F764A6;jsessionid=5C7888C1C796D7E3ECF861FCDD776DA6;jsessionid=74B18F0C6747DA6C3D2A03F49031111C;jsessionid=0350987D2F0E608EE51FB54145DD28D3;jsessionid=E90B2011B15785E1DB6623948C4D8DE7;jsessionid=FFCCA38EB104610ED41F1F973B173DE1 (gene)

1. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
2. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
3. The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissue…
4. Ataxin-2 gene: a powerful modulator of neurological disorders.
5. Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A10F0BAC488BB1596C5F0CE4F667FB3F;jsessionid=4604EAF85061B7D2112CE838C4F764A6;jsessionid=5C7888C1C796D7E3ECF861FCDD776DA6;jsessionid=74B18F0C6747DA6C3D2A03F49031111C;jsessionid=0350987D2F0E608EE51FB54145DD28D3;jsessionid=E90B2011B15785E1DB6623948C4D8DE7;jsessionid=FFCCA38EB104610ED41F1F973B173DE1